Cardiovascular Disease Predicts Structural and Functional Progression in Early Glaucoma.
Aged
Cardiovascular Diseases
/ complications
Disease Progression
Female
Follow-Up Studies
Glaucoma
/ complications
Humans
Intraocular Pressure
/ physiology
Male
Middle Aged
Nerve Fibers
/ pathology
Optic Disk
/ pathology
Prognosis
Prospective Studies
Retinal Ganglion Cells
/ pathology
Time Factors
Tomography, Optical Coherence
/ methods
Visual Acuity
OCT
cardiovascular disease
glaucoma
Journal
Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
11
05
2020
revised:
24
06
2020
accepted:
30
06
2020
pubmed:
31
7
2020
medline:
13
4
2021
entrez:
31
7
2020
Statut:
ppublish
Résumé
To investigate the association between cardiovascular disease and baseline structural defects and disease progression in glaucoma. Prospective, longitudinal study of preperimetric and perimetric glaucoma. Two thousand six hundred twenty-eight eyes from 1314 participants recruited to the Progression Risk of Glaucoma: Relevant SNPs with Significant Association (PROGRESSA) study were evaluated for baseline and longitudinal structural thinning using spectral-domain OCT and for visual field progression on Humphrey visual field (HVF) assessment. Patients were classified as either predominantly macula ganglion cell-inner plexiform layer (mGCIPL), predominantly peripapillary retinal nerve fiber layer (pRNFL), or both mGCIPL and pRNFL structural change at enrollment, and then evaluated for longitudinal OCT or HVF progression. Cardiovascular disease and medication characteristics of the participants were compared with a reference group of stable patients. OCT and HVF baseline status and longitudinal progression. After accounting for age and cardiovascular characteristics, patients with predominantly mGCIPL thinning at baseline showed a higher prevalence of hypertension (odds ratio [OR], 2.70; 95% confidence interval [CI], 1.66-4.41; P < 0.001), antihypertensive use (OR, 2.03; 95% CI, 1.20-3.46; P = 0.008), and statin use (OR, 1.98; 95% CI, 1.07-3.66; P = 0.029) than reference patients. Patients with predominantly pRNFL thinning exhibited a comparable prevalence of cardiovascular disease or medication with reference patients. Review of longitudinal OCT and HVF data (mean follow-up, 5.34 ± 1.29 years) showed that hypertension was associated with an increased risk of both OCT (OR, 1.79; 95% CI, 1.17-2.75; P = 0.006) and HVF progression (OR, 1.92; 95% CI, 1.18-3.15; P = 0.013). A 1-standard deviation (approximately 21 mmHg) increase in systolic blood pressure at baseline was associated with a greater risk of OCT progression (OR, 1.27; 95% CI, 1.01-1.63; P = 0.041) and HVF progression (OR, 1.32; 95% CI, 1.01-1.73; P = 0.043). The association between systolic blood pressure and structural progression was comparable to that observed between intraocular pressure and structural progression (OR, 1.30; 95% CI, 1.01-1.67; P = 0.039). Cardiovascular disease is an important risk factor for glaucoma progression.
Identifiants
pubmed: 32730956
pii: S0161-6420(20)30706-5
doi: 10.1016/j.ophtha.2020.06.067
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
58-69Informations de copyright
Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.